FDA

Health care reform, the Dodd-Frank Act, environmental protection, and open government are discussed in our top news posts from 2011.

Legislation seeks to speed FDA review of medical products.

Governmental and nongovernmental action taken to discourage illegal pharmaceutical sales over the Internet.

“Network of Experts” intended to give FDA quicker information on emerging medical devices.

Agency intends to prohibit the sale of synthetic stimulants, at least temporarily.

Leading scholars analyze whether regulation has suffered a breakdown.

Advocacy group petitions agency to let generic drug manufacturers update labels.

Agency reports on pilot programs to increase international regulatory collaboration.

The agency details its plans to enhance transparency, public collaboration.

Nine bold warnings approved for display.

EPA, FDA respond with calls for public comments.

Committee members urge FDA to expedite releasing industry guidance.